218 related articles for article (PubMed ID: 8402886)
1. Small molecules that selectively block RNA binding of HIV-1 Rev protein inhibit Rev function and viral production.
Zapp ML; Stern S; Green MR
Cell; 1993 Sep; 74(6):969-78. PubMed ID: 8402886
[TBL] [Abstract][Full Text] [Related]
2. Modulation of the Rev-RRE interaction by aromatic heterocyclic compounds.
Zapp ML; Young DW; Kumar A; Singh R; Boykin DW; Wilson WD; Green MR
Bioorg Med Chem; 1997 Jun; 5(6):1149-55. PubMed ID: 9222509
[TBL] [Abstract][Full Text] [Related]
3. A non-canonical base pair within the human immunodeficiency virus rev-responsive element is involved in both rev and small molecule recognition.
Werstuck G; Zapp ML; Green MR
Chem Biol; 1996 Feb; 3(2):129-37. PubMed ID: 8807838
[TBL] [Abstract][Full Text] [Related]
4. RNA-ligand interactions: affinity and specificity of aminoglycoside dimers and acridine conjugates to the HIV-1 Rev response element.
Luedtke NW; Liu Q; Tor Y
Biochemistry; 2003 Oct; 42(39):11391-403. PubMed ID: 14516190
[TBL] [Abstract][Full Text] [Related]
5. The herpes simplex virus 1 Us11 protein cooperates with suboptimal amounts of human immunodeficiency virus type 1 (HIV-1) Rev protein to rescue HIV-1 production.
Duc Dodon M; Mikaélian I; Sergeant A; Gazzolo L
Virology; 2000 Apr; 270(1):43-53. PubMed ID: 10772978
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of HIV-1 replication by targeting the Rev protein.
Nakaya T; Iwai S; Fujinaga K; Otsuka E; Ikuta K
Leukemia; 1997 Apr; 11 Suppl 3():134-7. PubMed ID: 9209321
[TBL] [Abstract][Full Text] [Related]
7. Aminoglycoside antibiotics, neamine and its derivatives as potent inhibitors for the RNA-protein interactions derived from HIV-1 activators.
Hamasaki K; Ueno A
Bioorg Med Chem Lett; 2001 Feb; 11(4):591-4. PubMed ID: 11229778
[TBL] [Abstract][Full Text] [Related]
8. [Synthesis of biomimetic analogs of neomycin B].
Nishizono N
Yakugaku Zasshi; 2002 Jul; 122(7):465-9. PubMed ID: 12136642
[TBL] [Abstract][Full Text] [Related]
9. Trans-activating rev protein of the human immunodeficiency virus 1 interacts directly and specifically with its target RNA.
Daefler S; Klotman ME; Wong-Staal F
Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4571-5. PubMed ID: 2191294
[TBL] [Abstract][Full Text] [Related]
10. Molecular and virological effects of intracellular anti-Rev single-chain variable fragments on the expression of various human immunodeficiency virus-1 strains.
Duan L; Zhang H; Oakes JW; Bagasra O; Pomerantz RJ
Hum Gene Ther; 1994 Nov; 5(11):1315-24. PubMed ID: 7893803
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of neomycin and Rev peptide binding to the Rev responsive element of HIV-1 as determined by fluorescence and NMR spectroscopy.
Lacourciere KA; Stivers JT; Marino JP
Biochemistry; 2000 May; 39(19):5630-41. PubMed ID: 10801313
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Factor 90, a cellular dsRNA binding protein inhibits the HIV Rev-export function.
Urcuqui-Inchima S; Castaño ME; Hernandez-Verdun D; St-Laurent G; Kumar A
Retrovirology; 2006 Nov; 3():83. PubMed ID: 17125513
[TBL] [Abstract][Full Text] [Related]
13. HIV Rev-dependent binding of SF2/ASF to the Rev response element: possible role in Rev-mediated inhibition of HIV RNA splicing.
Powell DM; Amaral MC; Wu JY; Maniatis T; Greene WC
Proc Natl Acad Sci U S A; 1997 Feb; 94(3):973-8. PubMed ID: 9023367
[TBL] [Abstract][Full Text] [Related]
14. Characterization of HIV-1 REV protein: binding stoichiometry and minimal RNA substrate.
Cook KS; Fisk GJ; Hauber J; Usman N; Daly TJ; Rusche JR
Nucleic Acids Res; 1991 Apr; 19(7):1577-83. PubMed ID: 2027765
[TBL] [Abstract][Full Text] [Related]
15. Identification of a high-affinity RNA-binding site for the human immunodeficiency virus type 1 Rev protein.
Tiley LS; Malim MH; Tewary HK; Stockley PG; Cullen BR
Proc Natl Acad Sci U S A; 1992 Jan; 89(2):758-62. PubMed ID: 1731351
[TBL] [Abstract][Full Text] [Related]
16. HIV-1 structural gene expression requires binding of the Rev trans-activator to its RNA target sequence.
Malim MH; Tiley LS; McCarn DF; Rusche JR; Hauber J; Cullen BR
Cell; 1990 Feb; 60(4):675-83. PubMed ID: 2406030
[TBL] [Abstract][Full Text] [Related]
17. Methylphosphonate mapping of phosphate contacts critical for RNA recognition by the human immunodeficiency virus tat and rev proteins.
Pritchard CE; Grasby JA; Hamy F; Zacharek AM; Singh M; Karn J; Gait MJ
Nucleic Acids Res; 1994 Jul; 22(13):2592-600. PubMed ID: 8041622
[TBL] [Abstract][Full Text] [Related]
18. Positive and negative modulation of human immunodeficiency virus type 1 Rev function by cis and trans regulators of viral RNA splicing.
Pongoski J; Asai K; Cochrane A
J Virol; 2002 May; 76(10):5108-20. PubMed ID: 11967326
[TBL] [Abstract][Full Text] [Related]
19. Direct observation of aminoglycoside-RNA interactions by surface plasmon resonance.
Hendrix M; Priestley ES; Joyce GF; Wong CH
J Am Chem Soc; 1997 Apr; 119(16):3641-8. PubMed ID: 11540136
[TBL] [Abstract][Full Text] [Related]
20. The amino terminal domain of HIV-1 Rev is required for discrimination of the RRE from nonspecific RNA.
Daly TJ; Doten RC; Rusche JR; Auer M
J Mol Biol; 1995 Oct; 253(2):243-58. PubMed ID: 7563086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
